His primary scientific interests are in Rheumatoid arthritis, Physical therapy, Internal medicine, Arthritis and Severity of illness. His Rheumatoid arthritis study combines topics in areas such as Autoimmune disease and Disease. He usually deals with Disease and limits it to topics linked to Synovitis and Anti–citrullinated protein antibody.
His Physical therapy study integrates concerns from other disciplines, such as Clinical trial, Psoriatic arthritis, Alternative medicine, Evidence-based medicine and Rheumatism. His work in Internal medicine addresses issues such as Surgery, which are connected to fields such as Rheumatoid factor. His biological study spans a wide range of topics, including Connective tissue disease, Infliximab, Immunopathology and Abatacept.
Daniel Aletaha mainly investigates Rheumatoid arthritis, Internal medicine, Physical therapy, Arthritis and Rheumatology. His work in Rheumatoid arthritis covers topics such as Disease activity which are related to areas like Clinical disease. Daniel Aletaha has researched Internal medicine in several fields, including Gastroenterology and Immunology.
His Physical therapy research incorporates elements of Systematic review, Intensive care medicine, Alternative medicine, Rheumatism and Severity of illness. His Arthritis research integrates issues from Pharmacotherapy and Combination therapy. His Rheumatology study also includes
Daniel Aletaha mostly deals with Rheumatoid arthritis, Internal medicine, In patient, Arthritis and Psoriatic arthritis. His Rheumatoid arthritis study incorporates themes from Radiography and Intensive care medicine. His biological study spans a wide range of topics, including Clinical trial and Evidence-based medicine.
Internal medicine is closely attributed to Gastroenterology in his study. His Arthritis research is multidisciplinary, incorporating elements of Tumor necrosis factor alpha, Proinflammatory cytokine, Ankylosing spondylitis and Epigenetics. The study incorporates disciplines such as Oral treatment, Etanercept and Adult patients in addition to Psoriatic arthritis.
Daniel Aletaha focuses on Rheumatoid arthritis, Internal medicine, Intensive care medicine, Arthritis and Kappa. His Rheumatoid arthritis study integrates concerns from other disciplines, such as Disease activity and Rheumatism. The concepts of his Rheumatism study are interwoven with issues in Quality of life, Simplified disease activity index, Early ra, Recursive partitioning and Rheumatology.
His research integrates issues of Gastroenterology and Finger joint in his study of Internal medicine. The various areas that Daniel Aletaha examines in his Intensive care medicine study include Disease management, Clinical trial and Evidence-based medicine. His Arthritis study combines topics in areas such as T cell, Cancer research, Downregulation and upregulation and Pathogenesis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.
Daniel Aletaha;Tuhina Neogi;Alan J. Silman;Julia Funovits.
Annals of the Rheumatic Diseases (2010)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Josef S Smolen;Robert Landewé;Ferdinand C Breedveld;Maya Buch;Maya Buch.
Annals of the Rheumatic Diseases (2014)
Treating rheumatoid arthritis to target: recommendations of an international task force
Josef S. Smolen;Daniel Aletaha;Johannes W J W Bijlsma;Ferdinand C Breedveld.
Annals of the Rheumatic Diseases (2010)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
Josef S. Smolen;Robert Landewé;Ferdinand C Breedveld;Maxime Dougados.
Annals of the Rheumatic Diseases (2010)
American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
David T. Felson;David T. Felson;Josef S. Smolen;George Wells;Bi Zhang.
Arthritis & Rheumatism (2011)
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
Josef S Smolen;Ferdinand C Breedveld;Gerd R Burmester;Vivian Bykerk.
Annals of the Rheumatic Diseases (2016)
New therapies for treatment of rheumatoid arthritis
Josef S Smolen;Daniel Aletaha;Marcus Koeller;Michael H Weisman.
The Lancet (2007)
Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score
Daniel Aletaha;Valerie P K Nell;Tanja Stamm;Martin Uffmann.
Arthritis Research & Therapy (2005)
European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update.
L Gossec;J S Smolen;S Ramiro;M de Wit.
Annals of the Rheumatic Diseases (2016)
The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis
D Aletaha;J Smolen.
Clinical and Experimental Rheumatology (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Medical University of Vienna
University of Vienna
University of Leeds
University of Amsterdam
Leiden University Medical Center
University of Oslo
Hôpital Cochin
Boston University
University of Montpellier
University of Glasgow
Stanford University
King Abdulaziz University
Dalian Institute of Chemical Physics
Rutgers, The State University of New Jersey
University of Bristol
Memorial University of Newfoundland
Ludwig-Maximilians-Universität München
University of Toronto
University of Liège
University of Malaya
Pacific Marine Environmental Laboratory
Osaka University
Juntendo University
Newcastle University
Duke University
International Survey Center